Company’s Banking Shares: Up 8.67% from 52-Week Low, But Can the Momentum Hold?

NeuroSense Therapeutics Ltd’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $1.50 on 05/20/25 and a low of $0.51 for the same time frame on 07/19/24.

52-week price history of NRSN Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. NeuroSense Therapeutics Ltd’s current trading price is 8.67% away from its 52-week high, while its distance from the 52-week low is 218.36%. The stock’s price range during this period has spanned from $0.51 to $1.50. In the Healthcare sector, the NeuroSense Therapeutics Ltd’s shares surpassed a trading volume of approximately 0.72 million for the day, which was noticeably higher compared to the average daily volume of 9.0.15 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

NeuroSense Therapeutics Ltd (NRSN) has experienced a quarterly rise of 44.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 39.10M and boasts a workforce of 15 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0986, with a change in price of +0.3800. Similarly, NeuroSense Therapeutics Ltd recorded 165,767 in trading volume during the last 100 days, posting a change of +30.40%.

Examining NRSN’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for NRSN stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.00.

NRSN Stock Stochastic Average

Today, NeuroSense Therapeutics Ltd’s raw stochastic average for the past 50 days stands at 100.00%, indicating a rise from the raw stochastic average of the last 20 days, which was 100.00%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 93.48% and 83.52% respectively.

NRSN Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 35.83%. However, over the last six months, the performance has been weaker by 25.38%. The price of NRSN increased 63.00% over the last 30 days. And in the last five days, it has surged by 29.37%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.